Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.
Research / 03 August 2021
With multiple medicine use on the rise, a UK study has set out to gather evidence for safer practices to get patients off the drugs they no longer need.
Research / 16 June 2021
Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Research / 09 April 2021
Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020
Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.